Skip to main content

People in the News: Junying Yuan, John Ornell, Eugene Cassis

Premium

Agilent this week awarded Chinese Academy of Sciences researcher Junying Yuan an Agilent Thought Leader award in recognition of her research in cellular biology and neurodegenerative diseases.

Yuan and her team use mass spectrometry to study interactions of metabolite-protein, protein-protein and genetic networks involved in the etiology of neurodegenerative disease. Primarily focused on metabolomics, she now plans to integrate her lab's metabolomic data with transcriptomic and proteomic data with the aim of identifying protein targets or biomarkers linked to neurodegenerative disease.


Waters' John Ornell plans to resign from his post as chief financial officer, effective Feb. 1, 2014, after which he will continue to serve the company as an advisor on a part-time basis.

Eugene Cassis, who currently is corporate VP of worldwide business development and investor relations, will step into the CFO role on an interim basis when Ornell leaves the position. Cassis has been with the company for 33 years and has an extensive background in the firm's financial, operational, and technical activities.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.